Cover Image
市場調查報告書

基底細胞癌 (基底細胞上皮瘤) :全球臨床實驗趨勢

Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 233634
出版日期 內容資訊 英文 143 Pages
訂單完成後即時交付
價格
Back to Top
基底細胞癌 (基底細胞上皮瘤) :全球臨床實驗趨勢 Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2017
出版日期: 2017年04月30日 內容資訊: 英文 143 Pages
簡介

本報告提供基底細胞癌 (基底細胞上皮瘤) 相關臨床研究最新趨勢分析,以疾病概要為首,提供您G7各國·E7各國的臨床實驗狀況,各地區、各階段的進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上基底細胞癌 (基底細胞上皮瘤)的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:癌症治療藥臨床實驗上基底細胞癌 (基底細胞上皮瘤)的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

基底細胞癌 (基底細胞上皮瘤) 治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2017" provides an overview of Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials scenario. This report provides top line data relating to the clinical trials on Basal Cell Carcinoma (Basal Cell Epithelioma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials 20
  • Clinical Trials by Phase in E7 Countries 22
  • Clinical Trials in E7 Countries by Trial Status 23
  • Clinical Trials by Phase 24
  • In Progress Trials by Phase 25
  • Clinical Trials by Trial Status 26
  • Clinical Trials by End Point Status 27
  • Subjects Recruited Over a Period of Time 28
  • Clinical Trials by Sponsor Type 29
  • Prominent Sponsors 30
  • Top Companies Participating in Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials 32
  • Prominent Drugs 34
  • Latest Clinical Trials News on Basal Cell Carcinoma (Basal Cell Epithelioma) 36
  • Mar 03, 2017: Biosceptre publishes a clinical study of topical drug BIL010t as therapy for Basal cell carcinoma 36
  • Clinical Trial Profile Snapshots 37

Appendix 139

  • Abbreviations 139
  • Definitions 139
  • Research Methodology 140
  • Secondary Research 140
  • About GlobalData 141
  • Contact Us 141
  • Disclaimer 141
  • Source 142

List of Tables

List of Tables

  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
  • Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials, G7 Countries (%), 2017* 17
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials, E7 Countries (%), 2017* 20
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Phase, 2017* 24
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 29
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

List of Figures

List of Figures

  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
  • Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Basal Cell Carcinoma (Basal Cell Epithelioma) to Oncology Clinical Trials, E7 Countries (%), 2017* 20
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 27
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 28
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 29
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
  • Basal Cell Carcinoma (Basal Cell Epithelioma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34
  • GlobalData Methodology 140
Back to Top